Answers
An adjudicator should be able to understand the business as they need to determine whether it is credible. If your business is complex, the business plan should be presented in such a way as to present it in layman's terms, but then it should provide sufficient detail so that the layman's portion can be investigated and validated if need be.
If you are in the drug development business for example, the business plan should discuss the drugs, what they do, patents and an overview of how they work. The backup detail could be a brief explanation of molecular compounds, but the plan does not need to extend into a lesson of molecular biology.
Your business plan must be detailed and provide the necessary information. Try to keep things simple with respect to terminology, etc. Be sure that it is written so that it has the information, but in a manner that is in layman's terms. Use footnotes, etc. It is best to retain a business plan writer, who will understand the ins and outs of EB-5 business plans and what is expected.
Upcoming Events
Top Contributors
Latest Questions
Subscribe for News
Securities Disclaimer
This website is for informational purposes only and does not constitute an offer or solicitation to sell shares or securities. Any such offer or solicitation will be made only by means of an investment's confidential Offering Memorandum and in accordance with the terms of all applicable securities and other laws. This website does not constitute or form part of, and should not be construed as, any offer for sale or subscription of, or any invitation to offer to buy or subscribe for, any securities, nor should it or any part of it form the basis of, or be relied on in any connection with, any contract or commitment whatsoever. EB5Projects.com LLC and its affiliates expressly disclaim any and all responsibility for any direct or consequential loss or damage of any kind whatsoever arising directly or indirectly from: (i) reliance on any information contained in the website, (ii) any error, omission or inaccuracy in any such information or (iii) any action resulting therefrom.